This is the classic website, which will be retired eventually. Please visit the modernized instead.

Key Record Dates Identifier: NCT03981796
Brief Title: A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancer (RUBY)

First Submitted : May 31, 2019
First Submitted that Met QC Criteria : June 7, 2019
First Posted : June 11, 2019

Last Update Submitted that Met QC Criteria : August 8, 2023
Last Update Posted : August 14, 2023